These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease. Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y. Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370 [Abstract] [Full Text] [Related]
3. [Methylprednisolone pulse therapy in Kawasaki disease]. Miura M, Matsuoka M, Kohno K, Ohki H, Yoshiba S. Nihon Rinsho; 2008 Feb; 66(2):338-42. PubMed ID: 18265457 [Abstract] [Full Text] [Related]
4. Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. Hashino K, Ishii M, Iemura M, Akagi T, Kato H. Pediatr Int; 2001 Jun; 43(3):211-7. PubMed ID: 11380911 [Abstract] [Full Text] [Related]
5. Indirect-comparison meta-analysis of treatment options for patients with refractory Kawasaki disease. Chan H, Chi H, You H, Wang M, Zhang G, Yang H, Li Q. BMC Pediatr; 2019 May 17; 19(1):158. PubMed ID: 31101091 [Abstract] [Full Text] [Related]
6. Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial. Ogata S, Ogihara Y, Honda T, Kon S, Akiyama K, Ishii M. Pediatrics; 2012 Jan 17; 129(1):e17-23. PubMed ID: 22144699 [Abstract] [Full Text] [Related]
7. Methylprednisolone pulse therapy for massive lymphadenopathy in a child with intravenous immunoglobulin-resistant Kawasaki disease. Chen HH, Liu PM, Bong CN, Wu YT, Yang KD, Wang CL. J Microbiol Immunol Infect; 2005 Apr 17; 38(2):149-52. PubMed ID: 15843862 [Abstract] [Full Text] [Related]
8. Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial. Sundel RP, Baker AL, Fulton DR, Newburger JW. J Pediatr; 2003 Jun 17; 142(6):611-6. PubMed ID: 12838187 [Abstract] [Full Text] [Related]
14. Pulse methylprednisolone therapy in the treatment of immune globulin-resistant Kawasaki disease: case report and review of the literature. Hung JJ, Chiu CH. Ann Trop Paediatr; 2004 Mar 17; 24(1):89-93. PubMed ID: 15005973 [Abstract] [Full Text] [Related]
15. Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP. Nobile-Orazio E, Cocito D, Jann S, Uncini A, Messina P, Antonini G, Fazio R, Gallia F, Schenone A, Francia A, Pareyson D, Santoro L, Tamburin S, Cavaletti G, Giannini F, Sabatelli M, Beghi E, IMC Trial Group. J Neurol Neurosurg Psychiatry; 2015 Jul 17; 86(7):729-34. PubMed ID: 25246645 [Abstract] [Full Text] [Related]
19. Role of glucocorticoids in Kawasaki disease. Miura M. Int J Rheum Dis; 2018 Jan 17; 21(1):70-75. PubMed ID: 29105310 [Abstract] [Full Text] [Related]